141 results on '"Horowitz, Netanel A."'
Search Results
102. Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia
103. Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
104. Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis.
105. Characteristics, Management and Outcome of DLBCL Patients Presenting with Simultaneous Systemic and CNS Disease at Diagnosis - a Retrospective Multicenter Study
106. Thrombosis in vasculitic disorders−clinical manifestations, pathogenesis and management
107. The role of pregnancy induced hormonal milieu in lymphoma progression
108. Efficacy and Safety of Single-Agent Ibrutinib in Patients with Mantle Cell Lymphoma Who Progressed after Bortezomib Therapy
109. Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study
110. Alterations in Platelet Levels of Brain-Derived Neurotrophic Factor Are Associated with Clinical Response to Bortezomib in Patients with Multiple Myeloma
111. Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy
112. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.
113. Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma.
114. Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation—can preemptive detection of John Cunningham virus be useful?
115. Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response
116. Preemptive Detection Of JC Virus In Peripheral Blood Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Potential Tool To Prevent Progressive Multifocal Leukoencephalopathy In High-Risk Patients?
117. Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma
118. Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3+7" induction regimen for acute myeloid leukemia.
119. New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib
120. Reactivation of JC Virus in 171 Allografted Patients: Incidence and Clinical Significance
121. Similar Frequency and Types of Neurological Complications in Patients Undergoing Matched Related and Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
122. Mechanisms coupling thrombomodulin to tumor dissemination
123. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain
124. Thrombin-Thrombomodulin Interactions Are An Important Determinant of Metastatic Potential
125. Colitis-Associated Cancer Is Dependent on the Interplay between the Hemostatic and Inflammatory Systems and Supported by Integrin αMβ2 Engagement of Fibrinogen
126. Fibrinogen Supports Colitis-Associated Adenoma Progression through a Mechanism Coupled to Engagement of the Leukocyte Integrin αMβ2.
127. Hemostatic Factors Support Colitis and Colitis-Associated Colon Cancer
128. Thrombophilia and Cancer
129. Thrombophilia and Cancer.
130. Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis
131. Thrombosis in vasculitic disorders − clinical manifestations, pathogenesis and management.
132. Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.
133. Hospital solution for COVID-19 isolation facility.
134. Israeli underground hospital conversion for treating COVID-19 patients.
135. BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.
136. Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.
137. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
138. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
139. Which patients should I transplant with acute lymphoblastic leukemia?
140. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries.
141. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.